| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |